|
Name |
(1S,2R,3E,5R,7S,9E,11R,12S,14S,15R,16S)-16-benzyl-2,5,12-trihydroxy-5,7,14-trimethyl-13-methylidene-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-18-one
|
Molecular Formula | C28H37NO4 | |
IUPAC Name* |
(1S,2R,3E,5R,7S,9E,11R,12S,14S,15R,16S)-16-benzyl-2,5,12-trihydroxy-5,7,14-trimethyl-13-methylidene-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-18-one
|
|
SMILES |
C[C@H]1C/C=C/[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@]2([C@@H](/C=C/[C@](C1)(C)O)O)C(=O)N[C@H]3CC4=CC=CC=C4)C)O
|
|
InChI |
InChI=1S/C28H37NO4/c1-17-9-8-12-21-25(31)19(3)18(2)24-22(15-20-10-6-5-7-11-20)29-26(32)28(21,24)23(30)13-14-27(4,33)16-17/h5-8,10-14,17-18,21-25,30-31,33H,3,9,15-16H2,1-2,4H3,(H,29,32)/b12-8+,14-13+/t17-,18+,21-,22-,23+,24-,25+,27-,28-/m0/s1
|
|
InChIKey |
UKQNIEMKORIOQM-WOMWMPBSSA-N
|
|
Synonyms |
Cytochalasin j; 53760-20-6
|
|
CAS | 53760-20-6 | |
PubChem CID | 155859132 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 451.6 | ALogp: | 2.8 |
HBD: | 4 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 33 | QED Weighted: | 0.513 |
Caco-2 Permeability: | -5.489 | MDCK Permeability: | 0.00000864 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.981 |
Human Intestinal Absorption (HIA): | 0.266 | 20% Bioavailability (F20%): | 0.193 |
30% Bioavailability (F30%): | 0.01 |
Blood-Brain-Barrier Penetration (BBB): | 0.536 | Plasma Protein Binding (PPB): | 77.01% |
Volume Distribution (VD): | 1.107 | Fu: | 5.58% |
CYP1A2-inhibitor: | 0.036 | CYP1A2-substrate: | 0.129 |
CYP2C19-inhibitor: | 0.381 | CYP2C19-substrate: | 0.697 |
CYP2C9-inhibitor: | 0.45 | CYP2C9-substrate: | 0.49 |
CYP2D6-inhibitor: | 0.077 | CYP2D6-substrate: | 0.133 |
CYP3A4-inhibitor: | 0.892 | CYP3A4-substrate: | 0.225 |
Clearance (CL): | 6.332 | Half-life (T1/2): | 0.107 |
hERG Blockers: | 0.133 | Human Hepatotoxicity (H-HT): | 0.576 |
Drug-inuced Liver Injury (DILI): | 0.244 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.905 | Maximum Recommended Daily Dose: | 0.991 |
Skin Sensitization: | 0.147 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.979 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004918 | 0.850 | D06CWH | 0.267 | ||||
ENC004544 | 0.850 | D0V3ZA | 0.251 | ||||
ENC004468 | 0.810 | D0SP3D | 0.251 | ||||
ENC004370 | 0.784 | D0I0DL | 0.250 | ||||
ENC006133 | 0.782 | D0D7KC | 0.245 | ||||
ENC003170 | 0.769 | D09NNH | 0.244 | ||||
ENC005761 | 0.750 | D01TSI | 0.244 | ||||
ENC003169 | 0.750 | D05VQI | 0.237 | ||||
ENC004369 | 0.733 | D0R1BD | 0.232 | ||||
ENC005132 | 0.733 | D03IKT | 0.230 |